Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P & C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)
Condition: Healthy Interventions: Drug: Apipe (Aripiprazole10 mg); Drug: Abilify (Aripiprazole10 mg) Sponsors: Genuine Research Center, Egypt; P&C Labs, Egypt Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials